Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays
Critical Care2008Vol. 12(4), pp. R94–R94
Citations Over TimeTop 10% of 2008 papers
Alexander Lukasz, Julian Hellpap, R. Horn, Jan T. Kielstein, Sascha David, Hermann Haller, Philipp Kümpers
Abstract
Ang-1 and Ang-2 might serve as a novel class of biomarker in critically ill patients. According to preclinical and clinical validation, circulating Ang-1 and Ang-2 can be reliably assessed by novel immunoassays in the intensive care unit setting.
Related Papers
- → Imbalance of Angiopoietin-1 and Angiopoetin-2 in Severe Dengue and Relationship with Thrombocytopenia, Endothelial Activation, and Vascular Stability(2012)84 cited
- Plasma concentration of angiopoietin-1, angiopoietin-2 and Tie-2 in cervical cancer.(2009)
- → ROLE OF ANGIOPOIETIN-1 AND ANGIOPOIETIN-2 IN GLIOMA ANGIOGENESIS(2004)
- The expression of angiopoietin-2 and its significance in placenta of pregnant women with FGR(2008)
- → P0646 / #1927: THE ROLE OF ANGIOPOIETIN IN PAEDIATRIC SEPSIS(2021)